Prognostic impact of 1q abnormality on outcomes in patients with newly diagnosed multiple myeloma treated with daratumumab, lenalidomide and dexamethasone in a real-world clinical setting.
作者信息
Kikuchi Taku, Tsukada Nobuhiro, Kunisada Kodai, Matsumoto Chiaki, Nomura-Yogo Moe, Oda Yuki, Sato Kota, Takei Tomomi, Ogura Mizuki, Abe Yu, Suzuki Kenshi, Hosoya Osamu, Ishida Tadao
机构信息
Department of Hematology, Japanese Red Cross Medical Center, 4-chōme-1-22 Hiroo, Shibuya-ku, Tokyo, 150-8935, Japan.
Department of Pharmacy, Japanese Red Cross Medical Center, Tokyo, Japan.
出版信息
Ann Hematol. 2024 Sep;103(9):3811-3813. doi: 10.1007/s00277-024-05835-4. Epub 2024 Jun 6.
PMID:38839622
Abstract
摘要
Zotero 插件